NSAC: UFC's Michal Oleksizjcuk gets one-year suspension for clomiphene

The Nevada State Athletic Comission today gave UFC light heavyweight Michal Oleksizjcuk a one-year suspension for a positive drug test stemming from UFC 219.

An NSAC official confirmed to MMAjunkie that Oleksizjcuk tested positive for clomiphene, a banned estrogen blocker that can be used in conjunction with performance-enhancers and was tabbed in anti-doping cases involving Jon Jones and Brock Lesnar.

Oleksizjcuk’s suspension is retroactive to Dec. 30, the date of an in-competition test that revealed the clomiphene. The NSAC also fined him 30 percent of his $12,000 purse, or $3,600, in addition to attorney’s fees of $436.08.

Oleksizjcuk’s (13-1 MMA, 0-0 UFC) unanimous decision win over Khalil Rountree (6-2 MMA, 2-2 UFC) is also overturned to a no-contest.

The 23-year-old Polish fighter also faces a concurrent case with UFC anti-doping partner USADA, which has yet to announce a decision. The UFC initially announced a potential anti-doping violation in late January as Oleksizjcuk was placed on temporary suspension.

Oleksizjcuk entered the UFC on a nine-fight win streak in international competition and upset Rountree, who’d won his past two fights.

To apply for another fight license in Nevada, Oleksizjcuk must provide a clean drug test 30, 15, and 3 days prior to being licensed. He must also pay his fines.

For complete coverage of UFC 219, check out the UFC Events section of the site.